Landscapes / Companies

Servier Bio-Innovation LLC not checked

FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
Approved
Next date
S095024, Phase 1/2 trial completes
Drugs
6
in active trials · 9 in all
Trials
5 active
9 since 2021

Drugs6

DrugHow it worksPartnerStageNext dateDetails
Isocitrate dehydrogenase 1 inhibitor
Approved 15 Oct 2027Phase 3 trial completes
—
Phase 1/2 Apr 2027Phase 1/2 trial completes
—
Phase 1/2 Apr 2027Phase 1/2 trial completes
—
Symphogen A/S
Phase 1/2 Apr 2027Phase 1/2 trial completes
—
Phase 1/2 1 May 2027Phase 1/2 trial completes
—
Tango Therapeutics
Phase 1/2 1 May 2027Phase 1/2 trial completes

About

No active trial
PRS-344/S095012, S227928, Vorasidenib
SEC filings
None: it does not file with the US SEC
Sources
ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021

Follow Servier Bio-Innovation LLC

Following is part of Solo: you see every change to Servier Bio-Innovation LLC the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in